Singapore markets open in 5 hours 34 minutes

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9816-0.0584 (-5.62%)
As of 03:26PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 95.00M
Enterprise value 49.34M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)167.43
Price/book (mrq)1.60
Enterprise value/revenue 98.68
Enterprise value/EBITDA -0.88

Trading information

Stock price history

Beta (5Y monthly) 0.21
52-week change 3-76.52%
S&P500 52-week change 3-0.65%
52-week high 39.7000
52-week low 30.9400
50-day moving average 31.2690
200-day moving average 33.8250

Share statistics

Avg vol (3-month) 31.83M
Avg vol (10-day) 32.21M
Shares outstanding 587.96M
Implied shares outstanding 6N/A
Float 878.44M
% held by insiders 110.52%
% held by institutions 123.64%
Shares short (28 Apr 2022) 48.22M
Short ratio (28 Apr 2022) 44.22
Short % of float (28 Apr 2022) 410.26%
Short % of shares outstanding (28 Apr 2022) 49.34%
Shares short (prior month 30 Mar 2022) 46.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-10,878.60%

Management effectiveness

Return on assets (ttm)-63.69%
Return on equity (ttm)-142.19%

Income statement

Revenue (ttm)500k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-85k
EBITDA -54.17M
Net income avi to common (ttm)-50.63M
Diluted EPS (ttm)-0.6530
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)77.97M
Total cash per share (mrq)0.89
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.93
Book value per share (mrq)0.69

Cash flow statement

Operating cash flow (ttm)-40.59M
Levered free cash flow (ttm)-21.21M